Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA

Kylie C Horne; Benjamin Peter Howden; Elizabeth A Grabsch; M Graham; B P Ward; Shirley Xie; B C Mayall; Paul DR Johnson; M Lindsay Grayson

doi:10.1128/AAC.01365-08

Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA

Kylie C Horne, Benjamin Peter Howden, Elizabeth A Grabsch, M Graham, B P Ward, Shirley Xie, B C Mayall, Paul DR Johnson, M Lindsay Grayson

Research output: Contribution to journal › Article › Research › peer-review

102 Citations (Scopus)

Original language	English
Pages (from-to)	3447 - 3452
Number of pages	6
Journal	Antimicrobial Agents and Chemotherapy
Volume	53
Issue number	8
DOIs	https://doi.org/10.1128/AAC.01365-08
Publication status	Published - 2009

Access to Document

10.1128/AAC.01365-08

Cite this

Horne, K. C., Howden, B. P., Grabsch, E. A., Graham, M., Ward, B. P., Xie, S., Mayall, B. C., Johnson, P. DR., & Grayson, M. L. (2009). Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA. Antimicrobial Agents and Chemotherapy, 53(8), 3447 - 3452. https://doi.org/10.1128/AAC.01365-08

@article{aa7dfc9d1a8d4963b755b8a6346865ae,

title = "Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA",

author = "Horne, {Kylie C} and Howden, {Benjamin Peter} and Grabsch, {Elizabeth A} and M Graham and Ward, {B P} and Shirley Xie and Mayall, {B C} and Johnson, {Paul DR} and Grayson, {M Lindsay}",

year = "2009",

doi = "10.1128/AAC.01365-08",

language = "English",

volume = "53",

pages = "3447 -- 3452",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "8",

}

Horne, KC, Howden, BP, Grabsch, EA, Graham, M, Ward, BP, Xie, S, Mayall, BC, Johnson, PDR & Grayson, ML 2009, 'Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA', Antimicrobial Agents and Chemotherapy, vol. 53, no. 8, pp. 3447 - 3452. https://doi.org/10.1128/AAC.01365-08

Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA. / Horne, Kylie C; Howden, Benjamin Peter; Grabsch, Elizabeth A et al.
In: Antimicrobial Agents and Chemotherapy, Vol. 53, No. 8, 2009, p. 3447 - 3452.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA

AU - Horne, Kylie C

AU - Howden, Benjamin Peter

AU - Grabsch, Elizabeth A

AU - Graham, M

AU - Ward, B P

AU - Xie, Shirley

AU - Mayall, B C

AU - Johnson, Paul DR

AU - Grayson, M Lindsay

PY - 2009

Y1 - 2009

UR - http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19506056

U2 - 10.1128/AAC.01365-08

DO - 10.1128/AAC.01365-08

M3 - Article

SN - 0066-4804

VL - 53

SP - 3447

EP - 3452

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

IS - 8

ER -

Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA

Access to Document

Other files and links

Cite this